Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Dec;87(23):9188–9192. doi: 10.1073/pnas.87.23.9188

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

S Shak 1, D J Capon 1, R Hellmiss 1, S A Marsters 1, C L Baker 1
PMCID: PMC55129  PMID: 2251263

Abstract

Respiratory distress and progressive lung destruction in cystic fibrosis can be attributed to bacterial persistence and the accumulation of viscous purulent secretions in the airways. More than 30 yr ago it was suggested that the large amounts of DNA in purulent secretions contribute to its viscosity and that bovine pancreatic DNase I could reduce the viscosity. To evaluate the potential clinical utility of recombinant human DNase I (rhDNase) in the treatment of cystic fibrosis, we have cloned, sequenced, and expressed rhDNase. Catalytic amounts of rhDNase greatly reduce the viscosity of purulent cystic fibrosis sputum, transforming it within minutes from a nonflowing viscous gel to a flowing liquid. The reduction in viscosity is associated with a decrease in size of DNA in the sputum. Inhalation of a rhDNase aerosol may be a simple direct approach that will help individuals with cystic fibrosis and other patients with pneumonia or bronchitis to clear their airways of purulent secretions.

Full text

PDF
9188

Images in this article

9190Image
on p.9190
9190Image
on p.9190
9191Image
on p.9191
9191Image
on p.9191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMSTRONG J. B., WHITE J. C. Liquefaction of viscous purulent exudates by deoxyribonuclease. Lancet. 1950 Dec 9;2(6641):739–742. doi: 10.1016/s0140-6736(50)91676-x. [DOI] [PubMed] [Google Scholar]
  2. Boat T. F., Cheng P. W., Iyer R. N., Carlson D. M., Polony I. Human respiratory tract secretion. Mucous glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis. Arch Biochem Biophys. 1976 Nov;177(1):95–104. doi: 10.1016/0003-9861(76)90419-7. [DOI] [PubMed] [Google Scholar]
  3. CHERNICK W. S., BARBERO G. J. Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis. Pediatrics. 1959 Nov;24:739–745. [PubMed] [Google Scholar]
  4. CHERNICK W. S., BARBERO G. J., EICHEL H. J. In-vitro evaluation of effect of enzymes on tracheobronchial secretions from patients withcystic fibrosis. Pediatrics. 1961 Apr;27:589–596. [PubMed] [Google Scholar]
  5. Charman J., Reid L. The effect of freezing, storing and thawing on the viscosity of sputum. Biorheology. 1973 Sep;10(3):295–301. doi: 10.3233/bir-1973-10302. [DOI] [PubMed] [Google Scholar]
  6. Davis S. D., Bruns W. T. Effects of sputum from patients with cystic fibrosis on the activity in vitro of 5 antimicrobial drugs on Pseudomonas aeruginosa. Am Rev Respir Dis. 1978 Jan;117(1):176–178. doi: 10.1164/arrd.1978.117.1.176. [DOI] [PubMed] [Google Scholar]
  7. Dulfano M. J., Adler K. B. Physical properties of sputum. VII. Rheologic properties and mucociliary transport. Am Rev Respir Dis. 1975 Sep;112(3):341–347. doi: 10.1164/arrd.1975.112.3.341. [DOI] [PubMed] [Google Scholar]
  8. Dulfano M. J., Adler K., Philippoff W. Sputum viscoelasticity in chronic bronchitis. Am Rev Respir Dis. 1971 Jul;104(1):88–98. doi: 10.1164/arrd.1971.104.1.88. [DOI] [PubMed] [Google Scholar]
  9. ELMES P. C., WHITE J. C. Deoxyribonuclease in the treatment of purulent bronchitis. Thorax. 1953 Dec;8(4):295–300. doi: 10.1136/thx.8.4.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Funakoshi A., Tsubota Y., Wakasugi H., Ibayashi H., Takagi Y. Purification and properties of human pancreatic deoxyribonuclease I. J Biochem. 1977 Dec;82(6):1771–1777. doi: 10.1093/oxfordjournals.jbchem.a131875. [DOI] [PubMed] [Google Scholar]
  11. Ito K., Minamiura N., Yamamoto T. Human urine DNase I: immunological identity with human pancreatic DNase I, and enzymic and proteochemical properties of the enzyme. J Biochem. 1984 May;95(5):1399–1406. doi: 10.1093/oxfordjournals.jbchem.a134747. [DOI] [PubMed] [Google Scholar]
  12. JOHNSON A. J., GOGER P. R., TILLETT W. S. The intravenous injection of bovine crystalline pancreatic desoxyribonuclease into patients. J Clin Invest. 1954 Dec;33(12):1670–1686. doi: 10.1172/JCI103048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Keal E. E. Biochemistry and rheology of sputum in asthma. Postgrad Med J. 1971 Mar;47(545):171–177. doi: 10.1136/pgmj.47.545.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  15. LIEBERMAN J. Enzymatic dissolution of pulmonary secretions. An in vitro study of sputum from patients with cystic fibrosis of pancreas. Am J Dis Child. 1962 Oct;104:342–348. [PubMed] [Google Scholar]
  16. Lauffer L., Garcia P. D., Harkins R. N., Coussens L., Ullrich A., Walter P. Topology of signal recognition particle receptor in endoplasmic reticulum membrane. 1985 Nov 28-Dec 4Nature. 318(6044):334–338. doi: 10.1038/318334a0. [DOI] [PubMed] [Google Scholar]
  17. Levy J., Smith A. L., Kenny M. A., Ramsey B., Schoenknecht F. D. Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum. J Infect Dis. 1983 Dec;148(6):1069–1076. doi: 10.1093/infdis/148.6.1069. [DOI] [PubMed] [Google Scholar]
  18. Liao T. H., Salnikow J., Moore S., Stein W. H. Bovine pancreatic deoxyribonuclease A. Isolation of cyanogen bromide peptides; complete covalent structure of the polypeptide chain. J Biol Chem. 1973 Feb 25;248(4):1489–1495. [PubMed] [Google Scholar]
  19. Lieberman J. Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis. JAMA. 1968 Jul 29;205(5):312–313. [PubMed] [Google Scholar]
  20. Lieberman J. Measurement of sputum viscosity in a cone-plate viscometer. I. Characteristics of sputum viscosity. Am Rev Respir Dis. 1968 Apr;97(4):654–661. doi: 10.1164/arrd.1968.97.4.654. [DOI] [PubMed] [Google Scholar]
  21. Lieberman J. Measurement of sputum viscosity in a cone-plate viscometer. II. An evaluation of mucolytic agents in vitro. Am Rev Respir Dis. 1968 Apr;97(4):662–672. doi: 10.1164/arrd.1968.97.4.662. [DOI] [PubMed] [Google Scholar]
  22. Litt M. Mucus rheology. Relevance to mucociliary clearance. Arch Intern Med. 1970 Sep;126(3):417–423. doi: 10.1001/archinte.126.3.417. [DOI] [PubMed] [Google Scholar]
  23. Love J. D., Hewitt R. R. The relationship between human serum and human pancreatic DNase I. J Biol Chem. 1979 Dec 25;254(24):12588–12594. [PubMed] [Google Scholar]
  24. MATTHEWS L. W., SPECTOR S., LEMM J., POTTER J. L. STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY. Am Rev Respir Dis. 1963 Aug;88:199–204. doi: 10.1164/arrd.1963.88.2.199. [DOI] [PubMed] [Google Scholar]
  25. Marks M. I. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr. 1981 Feb;98(2):173–179. doi: 10.1016/s0022-3476(81)80631-2. [DOI] [PubMed] [Google Scholar]
  26. Mendelman P. M., Smith A. L., Levy J., Weber A., Ramsey B., Davis R. L. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis. 1985 Oct;132(4):761–765. doi: 10.1164/arrd.1985.132.4.761. [DOI] [PubMed] [Google Scholar]
  27. Murai K., Yamanaka M., Akagi K., Anai M., Mukai T., Omae T. Purification and properties of deoxyribonuclease from human urine. Biochim Biophys Acta. 1978 Jan 26;517(1):186–194. doi: 10.1016/0005-2787(78)90046-1. [DOI] [PubMed] [Google Scholar]
  28. Oefner C., Suck D. Crystallographic refinement and structure of DNase I at 2 A resolution. J Mol Biol. 1986 Dec 5;192(3):605–632. doi: 10.1016/0022-2836(86)90280-9. [DOI] [PubMed] [Google Scholar]
  29. POTTER J. L., MATTHEWS L. W., LEMM J., SPECTOR S. Human pulmonary secretions in health and disease. Ann N Y Acad Sci. 1963 Mar 30;106:692–697. doi: 10.1111/j.1749-6632.1963.tb16677.x. [DOI] [PubMed] [Google Scholar]
  30. Potter J. L., Matthews L. W., Spector S., Lemm J. Complex formation between basic antibiotics and deoxyribonucleic acid in human pulmonary secretions. Pediatrics. 1965 Nov;36(5):714–720. [PubMed] [Google Scholar]
  31. Potter J. L., Matthews L. W., Spector S., Lemm J. Studies on pulmonary secretions. II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am Rev Respir Dis. 1967 Jul;96(1):83–87. doi: 10.1164/arrd.1967.96.1.83. [DOI] [PubMed] [Google Scholar]
  32. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  33. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  34. Rosenthal A. L., Lacks S. A. Nuclease detection in SDS-polyacrylamide gel electrophoresis. Anal Biochem. 1977 May 15;80(1):76–90. doi: 10.1016/0003-2697(77)90627-3. [DOI] [PubMed] [Google Scholar]
  35. SALOMON A., HERCHFUS J. A., SEGAL M. S. Aerosols of pancreatic dornase in bronchopulmonary disease. Ann Allergy. 1954 Jan-Feb;12(1):71–77. [PubMed] [Google Scholar]
  36. SPIER R., WITEBSKY E., PAINE J. R. Aerosolized pancreatic dornase and antibiotics in pulmonary infections: use in patients with postoperative and nonoperative infections. JAMA. 1961 Dec 2;178:878–886. doi: 10.1001/jama.1961.03040480008003. [DOI] [PubMed] [Google Scholar]
  37. Smith A. L., Redding G., Doershuk C., Goldmann D., Gore E., Hilman B., Marks M., Moss R., Ramsey B., Rubio T. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr. 1988 Apr;112(4):547–554. doi: 10.1016/s0022-3476(88)80165-3. [DOI] [PubMed] [Google Scholar]
  38. Suck D., Oefner C., Kabsch W. Three-dimensional structure of bovine pancreatic DNase I at 2.5 A resolution. EMBO J. 1984 Oct;3(10):2423–2430. doi: 10.1002/j.1460-2075.1984.tb02149.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Vaudaux P., Waldvogel F. A. Gentamicin inactivation in purulent exudates: role of cell lysis. J Infect Dis. 1980 Oct;142(4):586–593. doi: 10.1093/infdis/142.4.586. [DOI] [PubMed] [Google Scholar]
  40. Wood R. E., Boat T. F., Doershuk C. F. Cystic fibrosis. Am Rev Respir Dis. 1976 Jun;113(6):833–878. doi: 10.1164/arrd.1976.113.6.833. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES